Psychosis News and Research RSS Feed - Psychosis News and Research

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''
Pregnant women with bipolar disorder at higher risk for developing postpartum psychosis

Pregnant women with bipolar disorder at higher risk for developing postpartum psychosis

Pregnant women with bipolar disorder and their families and physicians should be aware of a significantly higher risk for developing postpartum psychosis, according to a new Northwestern Medicine review of literature on the rare and under-researched disorder. [More]
Study reveals increasing prevalence of marijuana use among US adults

Study reveals increasing prevalence of marijuana use among US adults

An increasing number of US adults are using marijuana, as fewer people perceive the drug as harmful, according to a survey of over 500000 US adults conducted between 2002 and 2014 published in The Lancet Psychiatry. [More]
Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Study explores relationship between moderate-vigorous exercise and psychotic symptoms

Physical activity can help reduce cardiovascular disease and premature mortality in people with psychological problems. [More]
Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Boosting levels of a specific protein in the brain alleviates hallmark features of Alzheimer's disease in a mouse model of the disorder, according to new research published online August 25, 2016 in Scientific Reports. [More]
People with psychosis engage in low levels of physical activity, study reveals

People with psychosis engage in low levels of physical activity, study reveals

A large international study of more than 200,000 people in nearly 50 countries has revealed that people with psychosis engage in low levels of physical activity, and men with psychosis are over two times more likely to miss global activity targets compared to people without the illness. [More]
Drugs designed to target nervous system could control inflammation in the gut, study shows

Drugs designed to target nervous system could control inflammation in the gut, study shows

There's a reason it's called a gut feeling. The brain and the gut are connected by intricate neural networks that signal hunger and satiety, love and fear, even safety and danger. These networks employ myriad chemical signals that include dopamine, a powerful neurotransmitter most famous for its role in reward and addiction. [More]
Scientists explore neurobiological factors contributing to schizophrenia

Scientists explore neurobiological factors contributing to schizophrenia

Schizophrenic psychoses are a frequently occurring group of psychiatric disorders caused by a combination of biological, social and environmental factors. [More]
Antiepileptic drugs for reducing seizures may induce psychotic disorders, study shows

Antiepileptic drugs for reducing seizures may induce psychotic disorders, study shows

Today Brain publishes a new study indicating that antiepileptic drugs designed to reduce seizures, may also induce psychotic disorders in some patients. [More]
Prolonged duration of untreated early-onset psychosis predicts lower functional improvement in children

Prolonged duration of untreated early-onset psychosis predicts lower functional improvement in children

A review of 35 studies of early-onset schizophrenia-spectrum psychosis (EOS) identified the most common psychotic symptoms and the disorders that most often co-occur in children and adolescents with EOS. [More]
People with bipolar disorder not diagnosed until six years after onset of symptoms, study finds

People with bipolar disorder not diagnosed until six years after onset of symptoms, study finds

Crucial opportunities to manage bipolar disorder early are being lost because individuals are waiting an average of almost six years after the onset of the condition before diagnosis and treatment. [More]
Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana reduces use of prescription drugs, research finds

Medical marijuana is having a positive impact on the bottom line of Medicare's prescription drug benefit program in states that have legalized its use for medicinal purposes, according to University of Georgia researchers in a study published today in the July issue of Health Affairs. [More]
New risk calculator can assess individual's risk of developing psychosis

New risk calculator can assess individual's risk of developing psychosis

A new risk calculator can predict an individual's risk of developing psychotic disorders such as schizophrenia, according to a new study published today in The American Journal of Psychiatry. [More]
Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. ActharĀ® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses. [More]
Study finds link between stress hormone and stage of schizophrenia

Study finds link between stress hormone and stage of schizophrenia

JCU Associate Professor Zoltan Sarnyai said it was the first meta-analysis study to compare the level of cortisol in a waking patient's body with the stage of schizophrenia they are suffering. [More]
Mouse model of depression can help better understand how ketamine functions

Mouse model of depression can help better understand how ketamine functions

New research demonstrates the effectiveness of ketamine to treat depression in a mouse model of the disease and brings together two hypotheses for the cause of depression. [More]
Taking pregabalin drug during pregnancy could lead to major birth defects

Taking pregabalin drug during pregnancy could lead to major birth defects

A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

Studies show how speaking French could significantly reduce symptoms of Benign Essential Blepharospasm

A fascinating new study published in the latest edition of Movements Disorders (Vol.00 No.00, 2016) presents two patient case studies that demonstrate how speaking French as a second language can significantly reduce the symptoms of a life-limiting eye condition, Benign Essential Blepharospasm (BEB). [More]
New book reviews early detection approaches, possible interventions for psychosis

New book reviews early detection approaches, possible interventions for psychosis

It is essential for the benefit of patients and society to recognize an emerging psychosis early and provide appropriate treatment. This new volume reviews early detection approaches and possible subsequent interventions for psychosis. [More]
High prevalence of depression alongside COPD can impact overall health, treatment effectiveness

High prevalence of depression alongside COPD can impact overall health, treatment effectiveness

Although there have been discussions about chronic obstructive pulmonary disease (COPD), a condition impacting 24 million Americans, and depression, there has been little research showing the impact depression has on patients with COPD. Two studies published in the April issue of the journal CHEST found one in four patients with COPD suffer from depressive symptoms, and if not treated, those symptoms can have a negative effect on their overall health and treatment effectiveness. [More]
Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

Nuplazid (pimavanserin) tablets approved to treat hallucinations and delusions

The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease. [More]
Advertisement